Welcome to Clinical Trial Confidential.

We believe the clinical trial industry lacks a platform for open, transparent conversation. This lack of transparency inhibits progress. In this industry, that means patients are the ones that suffer.

Here you can choose to register an account, post anonymously or both. It is our hope that the ability to post anonymously will help foster useful conversation by allowing users to express their opinions without fear of retaliation, fear of appearing ignorant and otherwise allowing users to express opinions that may be contrary to their employer or that their position may not permit.

We believe great ideas should stand on their own merit and not the credentials of their author.

We hope these values will foster an environment of collaboration.

Hydroxychloroquine Dose for Autoimmune Diseases | Genericcures

Quote

The dose of hydroxychloroquine for autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus (lupus) is determined by a variety of criteria, including the specific ailment being treated, the severity of symptoms, and the patient's individual features. For rheumatoid arthritis, the initial dose of hydroxychloroquine is usually between 400 and 600 mg per day, either as a single dose or in two doses. For lupus, the first dose may be slightly lower, often between 200 and 400 mg per day. After many weeks of therapy, the dosage might be changed based on the patient's reaction and tolerance to the medicine.

Patients should carefully follow healthcare provider's recommendations and attend regular follow-up consultations to ensure that Hydroxychloroquine 200 mg Tablets medication is successful and safe. Dosage modifications may be required over time to obtain maximum symptom management while limiting the risk of adverse effects. Patients should also be informed of potential interactions with other medicines, as well as any additional precautions depending on their specific health situation.